Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,459 signal articles · 150 in last 24h · 154,156 total before filter · latest 45m ago
150last 24h
878last 7d
146● bullish (7d)
96● bearish (7d)
214publishers
AllMacro212Earnings108M&A125Regulatory21Product21Analyst17
✕ clear all filtersticker: ABTSentiment:bullishneutralbearishshow all (incl. clickbait)
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
Benzinga29d agoneutral
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization